Alvotech now has worldwide rights to manufacture and supply its global commercial partners with the aflibercept biosimilar.
Alvotech secures settlement agreement in global markets for Eyelea biosimilar
Related articles
More
Popular articles
Newsletter
Subscribe to get the latest news, offers and special announcements.